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Abstract
Background: Severe sepsis is a challenge for healthcare systems, and epidemiological studies are essential to assess
its burden and trends. However, there is no consensus on which coding strategy should be used to reliably identify
severe sepsis. This study assesses the use of explicit codes to define severe sepsis and the impacts of this on the
incidence and in-hospital mortality rates.
Methods: We examined episodes of severe sepsis in adults aged ≥18 years registered in the 2006–2011 national
hospital discharge database, identified in an exclusive manner by two ICD-9-CM coding strategies: (1) those
assigned explicit ICD-9-CM codes (995.92, 785.52); and (2) those assigned combined ICD-9-CM infection and organ
dysfunction codes according to modified Martin criteria. The coding strategies were compared in terms of the
populations they defined and their relative implementation. Trends were assessed using Joinpoint regression
models and expressed as annual percentage change (APC).
Results: Of 222 846 episodes of severe sepsis identified, 138 517 (62.2 %) were assigned explicit codes and 84 329
(37.8 %) combination codes; incidence rates were 60.6 and 36.9 cases per 100 000 inhabitants, respectively. Despite
similar demographic characteristics, cases identified by explicit codes involved fewer comorbidities, fewer registered
pathogens, greater extent of organ dysfunction (two or more organs affected in 60 % versus 26 % of cases) and
higher in-hospital mortality (54.5 % versus 29 %; risk ratio 1.86, 95 % CI 1.83, 1.88). Between 2006 and 2011, explicit
codes were increasingly implemented. Standardised incidence rates in this cohort increased over time with an
APC of 12.3 % (95 % CI 4.4, 20.8); in the combination code cohort, rates increased by 3.8 % (95 % CI 1.3, 6.3). A
decreasing trend in mortality was observed in both cohorts though the APC was −8.1 % (95 % CI −10.4, −5.7) in
the combination code cohort and −3.5 % (95 % CI −3.9, −3.2) in the explicit code cohort.
Conclusions: Our findings suggest greater and increasing use of explicit codes for adult severe sepsis in Spain.
This trend will have substantial impacts on epidemiological estimates, because these codes capture cases featuring
greater organ dysfunction and in-hospital mortality.
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Background
Adult severe sepsis is associated with high mortality,
morbidity and hospital costs [1–5] and remains a real
challenge for clinicians and health care systems [5–8].
Population estimates of severe sepsis and their trends
are essential to assess disease burden and estimate
healthcare resource requirements [3, 8–10].
Owing to the difficulty in prospectively identifying
cases at the population scale [8–11], population-based
studies of severe sepsis have been based on the
International Classification of Diseases, Ninth Edition,
Clinical Modification (ICD-9-CM). However, reported
incidence estimates of severe sepsis and related hospital
mortality vary widely from 13 to 300 cases per 100,000 in-
habitants and from 28 % to 50 %, respectively [1, 2, 4, 9].
Among other factors, this disparity seems to be deter-
mined by biases introduced by the different strategies used
to identify cases [9, 12, 13].
Following the definition in 1991 of severe sepsis as
sepsis associated with acute organ dysfunction [14],
population estimates of the incidence of severe sepsis
and its associated mortality have been based on com-
bination algorithms of ICD-9-CM infection and organ
dysfunction codes [15, 16]. Recognizing the limitations
of such algorithms, sometimes described as excessively
inclusive and with scarce specificity to represent real
cases of severe sepsis [10, 16, 17], in 2002, a set of expli-
cit ICD-9-CM codes was issued [18]. However, despite
this coding system having been developed more than
10 years ago, and the specificity being close to 100 %
[19], studies conducted in the USA indicate that the use
of this strategy is scarce and is restricted to patients with
more severe sepsis [13]. In effect, both for population-
based and other research studies, combination codes are
most widely used [9, 13]. However, it is not known if this
practice is generalized because no European population-
based studies have addressed the use of explicit severe
sepsis codes, and the impacts of the given coding system
used on epidemiological incidence and mortality esti-
mates are unknown.
The present study sought to identify cases of severe
sepsis captured by explicit and combination codes from
a national registry, and compare these two coding strat-
egies in terms of: (1) their implementation to identify
severe sepsis in adults in Spain and their impacts on
incidence estimates and (2) their definition of a given
profile of patient demographics, clinical characteristics
and hospital outcomes.
Methods
Design and data sources
We performed a retrospective study using the official
clinical-administrative database designated National
Minimum Basic Data Set (MBDS) of the Spanish Ministry
of Health, Social Services and Equality (MSSSI). In the
Spanish national health system, when a patient is
discharged from hospital, the responsible physician is
required by law to record all diagnoses and clinical proce-
dures performed using the ICD-9-CM system. This infor-
mation is compiled in the MBDS database. This database
is considered to be representative of the national popula-
tion as it includes data on over 90 % of all hospitalizations
in the country annually [19, 20].
In the MBDS, each hospitalization is treated as a spe-
cific record and includes information on patient demo-
graphics, type of admission, date of admission, date of
discharge, destiny upon discharge, along with diagnosis
codes including the principal diagnosis, 13 secondary
diagnoses and up to 20 procedures performed during
hospitalization. Hospitalization data for the study period
were obtained from the MSSSI [19] and data for the
general population were obtained from the National
Statistics Institute (Instituto Nacional de Estadística) [21].
Study population: case identification and definitions
We identified all hospitalizations of adult patients
(≥18 years) with severe sepsis from 1 January 2006 to 31
December 2011. To capture all cases, we used two estab-
lished ICD-9-CM diagnostic coding strategies [22–24],
generating two cohorts of longitudinal data. The first
strategy was based on explicit ICD-9-CM codes (995.92
for severe sepsis, 785.52 for septic shock) [9, 13, 18, 22]
and the second on ICD-9-CM infection and organ dys-
function combination codes according to modified
Martin criteria. This second strategy is detailed in
Additional file 1: Table S1. In addition, the codes are
given for septicaemia, fungaemia and bacteraemia as de-
scribed by Martin et al. [16, 22]. This strategy includes
the ICD-9-CM code for sepsis (995.91) introduced in
Spain in 2004. The two sets of codes were assigned in a
mutually exclusive fashion.
The codes defining organ dysfunction are provided in
Additional file 2: Table S2. The choice of this combin-
ation strategy was based on studies indicating its cap-
acity to estimate the burden of severe sepsis [23] and the
fact that it has been used in a previous study by our
group [24]. This provided us with two cohorts of longi-
tudinal data designated the explicit codes cohort and the
combination codes cohort.
We assessed the registry data for the 13 secondary
diagnosis fields using the version of the Charlson index
validated by Deyo for ICD-9-CM [25], to assess comor-
bidities [26]. This index includes specific comorbid con-
ditions of known prognostic value, which are classified
using ICD-9 codes from prior outpatient and in-patient
codes. Prior epidemiological studies in sepsis have
shown that there is no overlap between the codes used
to calculate this index and the diagnostic codes used to
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capture acute organ dysfunction [27], and that it is useful
in assessing the risk of death in septic patients [28]. For
identification of specific microorganisms, code 041 was in-
cluded as indicated by the ICD-9-CM coding manual for
the purpose of identifying bacterial agents in the case of
diseases classified under the heading “other” [20].
Ethics
All data were anonymized. According to Spanish legisla-
tion the use of these data is exempt of the need for
informed consent [29].
Data analysis
A descriptive comparative analysis was performed to com-
pare the use of explicit and combination coding practices
for severe sepsis, including data on patient demographics,
comorbidities, organ dysfunction and in-hospital mortal-
ity. In addition, in the explicit codes cohort, differentiation
was made between hospitalizations coded 785.52 (septic
shock) and those coded 995.92 (severe sepsis).
The Charlson-Deyo index was calculated according to
the improved STATA 14 package, both as a continuous
variable and as a categorical variable with four groups
(score 0, 1–2, 3–4 and >4) of increasing severity and
impact on outcome [30]. In-hospital mortality was calcu-
lated as the number of deaths divided by the number of
cases of severe sepsis in each cohort and expressed as a
percentage.
Qualitative variables were expressed as absolute fre-
quencies and percentages and quantitative variables as
means and standard deviations. Association between
qualitative variables was assessed using Pearson's chi-
squared test or Fisher's exact test, and between quantita-
tive and qualitative variables using Student's t test. We
used the risk ratio (RR) with its respective 95 % confi-
dence interval to quantify differences in demographic
and clinical data between the cohorts.
Incidence rates were estimated using national data for
subjects aged ≥18 years expressed as results per 100,000
inhabitants. Age-adjusted incidence and in-hospital mor-
tality rates were calculated by the direct standardization
method using the year 2008 as reference. To identify
trends in incidence and in-hospital mortality rates, we
quantified the annual percentage change (APC) with its
respective 95 % confidence interval, using log-linear re-
gression models assuming a standard Poisson distribution
[24, 31]. This procedure serves to determine whether an
apparent change in trend is statistically significant using a
Monte Carlo permutation method [31]. All statistical
tests were performed using the programmes STATA
14 (© 1985–2015 StataCorp LP. TX 77845 USA) and
Joinpoint Regression (version 4.2.0.2, 23 June 2015).
Significance was set at p < 0.05.
Results
Over the six-year period, there were 222 846 adult hos-
pitalizations for severe sepsis. The codes used for these
hospitalizations were combination in 84 329 (37.8 %)
and explicit in 138 517 (62.2 %). Among the latter, 93
380 cases (67 %) were coded 785.52 and 45 137 (33 %)
were coded 995.92.
General characteristics
Both the explicit code and combination code cohorts pre-
dominantly comprised men (Table 1) and mean age was
similar (71 years, p = 0.120). In contrast, hospitalizations
coded using explicit codes comprised a lower comorbidity
burden (mean Charlson index 2 vs. 2.2, p < 0.001) and a
lower percentage of cases in the categories of greater
severity. Further, with the exception of neoplasms, the fre-
quencies of each of the comorbidities included in the
Charlson index were also lower in this cohort than in the
combination code cohort. There were more surgical cases
among the patients assigned explicit codes.
Microorganisms were recorded in a significantly lower
proportion of cases in the explicit code cohort. Gram-
negative bacteria were the most frequently reported. As
potential sources of sepsis, the abdomen, respiratory
tract and soft tissues were significantly more frequently
recorded in this cohort than in the combination code
cohort. The possible source was not specified in 38 % of
the explicit code cohort and in 23 % of the combination
code cohort.
The extent of organ dysfunction differed significantly
between the two cohorts (Table 1). Thus, in the explicit
code group, a third of all episodes featured the dysfunc-
tion of one, two, or more than two organs, while in the
combination code cohort, 74 % of cases involved single-
organ dysfunction. When comparing affected organs,
cardiovascular, respiratory, kidney, haematological and
metabolic dysfunction were significantly more frequently
recorded in the explicit code cohort, as was the use of
invasive mechanical ventilation. It should be noted that
no data were available on the number or type of organ
dysfunction in 7 % of cases in the explicit code cohort.
Table 2 shows the characteristics of the cases recorded
in the explicit code cohort according to whether they
were coded 785.52 (septic shock) or 995.92 (severe sep-
sis). In this cohort, 67 % of cases were coded 785.52 and
corresponded to younger patients with fewer comorbidi-
ties and a greater number of organ dysfunctions, i.e., car-
diovascular, haematological, metabolic and respiratory,
and a greater need for mechanical ventilation support.
However, it should be noted that in a large proportion of
cases codified as 995.92, data were not available on the
number or type of dysfunctional organs. Gram-negative
microorganisms and respiratory sources of infection
were largely recorded in both groups.
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Table 1 General characteristics and in-hospital mortality recorded in the two cohorts examined (n = 222 846)
Explicit codes cohort
n = 138 517 (62.2)
Combination codes cohort
n = 84 329 (37.8)
RR (95 % CI)
Men 80 102 (57.8) 49 730 (59.0) 0.98 (0.97, 0.99)
Age groups (years)
18–44 10 355 (7.5) 7093 (8.4) 0.89 (0.86, 0.92)
45–64 30 129 (21.8) 17 187 (20.4) 1.07 (1.05, 1.09)
65–74 29 375 (21.2) 17 159 (20.4) 1.04 (1.02, 1.06)
75–84 44 348 (32.0) 26 801 (31.8) 1.01 (0.99, 1.02)
> 84 24 310 (17.6) 16 089 (19.1) 0.92 (0.90, 0.94)
Categorized Charlson index
0 32 843(23.7) 15 884 (18.8) 1.26 (1.24, 1.28)
1–2 63 820 (46.1) 37 781 (44.8) 1.03 (1.02, 1.04)
3–4 26 796 (19.3) 20 730 (24.6) 0.79 (0.77, 0.80)
> 4 15 058 (10.9) 9934 (11.8) 0.92 (0.90, 0.95)
Specific comorbiditiesa
Diabetes 29 243 (21.1) 20 207 (24.0) 0.88 (0.87, 0.90)
Cancer 28 064 (20.3) 15 321 (18.2) 1.12 (1.09, 1.14)
Chronic heart failure 23 053 (16.6) 14 024 (16.6) 1.00 (0.98, 1.02)
COPD 20 624 (14.9) 14 934 (17.7) 0.84 (0.82, 0.86)
Chronic renal disease 18 275 (13.2) 17 660 (20.9) 0.63 (0.62, 0.64)
Liver disease 17 408 (12.6) 10 616 (12.6) 1.00 (0.97, 1.02)
Cerebrovascular disease 10 394 (7.5) 8089 (9.6) 0.78 (0.76, 0.81)
Dementia 8139 (5.9) 5354 (6.3) 0.93 (0.89, 0.96)
Peripheral vascular disease 7515 (5.4) 4441 (5.3) 1.03(0.99, 1.07)
Acute myocardial infarction 5587 (4.0) 3800 (4.5) 0.90 (0.86, 0.93)
Surgical pathology 41 518 (30.0) 17 378 (20.6) 1.45 (1.43, 1.48)
Microbiological dataa
Pathogens identified: 52 946 (38.2) 52 641 (62.4) 0.61 (0.60, 0.62)
Gram-positive bacteria 21 591 (40.8) 25 804 (49.0) 0.83 (0.82, 0.85)
Gram-negative bacteria 36 765 (69.4) 30 944 (58.8) 1.18 (1.16, 1.20)
Fungi 1521 (2.9) 2525 (4.8) 0.60 (0.56, 0.64)
Site of infectiona
Respiratory system 35 176 (25.4) 18 572 (22.0) 1.15 (1.13, 1.17)
Genitourinary tract 28 517 (20.6) 22 507 (26.7) 0.77 (0.76, 0.78)
Abdomen 16 178 (11.7) 4414 (5.2) 2.23 (2.16, 2.31)
Central nervous system 1425 (1.0) 1082 (1.3) 0.80 (0.74, 0.87)
Procedure-related 13 608 (9.8) 9848 (11.7) 0.84 (0.82, 0.86)
Soft tissue 5285 (3.8) 2842 (3.4) 1.13 (1.08, 1.19)
Others/not specified 52 838 (38.2) 19 593 (23.2) 1.64 (1.62, 1.67)
Organ dysfunction (number of organs)
1 44 614 (32.2) 62 371 (74.0) 0.44 (0.43, 0.44)
2 41 994 (30.3) 16 956 (20.1) 1.51 (1.48, 1.54)
> 2 42 222 (30.5) 5002 (5.9) 5.14 (4.99, 5.30)
Not specifiedb 9687 (7.0) 0 Not applicable
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Trends in the use of explicit or combination codes
for severe sepsis
In 2006, 51 % and 49 % of cases were coded using expli-
cit and combination codes respectively. However, in the
last year of the study period (2011), these figures were
64.2 % and 35.8 % respectively. Trends in explicit coding
practices (Fig. 1) indicate the fairly stable use of code
785.52 (from 40.5 % to 40.2 % across the period) and a
notable increase in cases coded 995.92 (from 10.4 % in
2006 to 24 % in 2011).
Incidence
The episodes of severe sepsis identified amounted to
1.1 % of all adult hospitalizations over the 6-year period
and an overall incidence of 97.5 cases per 100,000 inhab-
itants. However, crude incidence rates were 36.9 cases
per 100 000 inhabitants for the combination codes and
60.6 cases per 100,000 inhabitants for the explicit codes.
In this cohort, incidence rates were 19.75 cases per
100,000 inhabitants for code 995.92 (severe sepsis) and
40.85 cases per 100 000 inhabitants for code 785.52
(septic shock).
From 2006 to 2011, the overall number of captured
cases increased from 25 808 to 46 774, representing an
annual increase of 13.5 %. Figure 1 shows the number of
cases of severe sepsis identified using explicit and com-
bination codes across the study interval. In the explicit
code cohort, adjusted incidence rates (Fig. 2) went from
36 cases per 100 000 inhabitants in 2006 to 73.6 per 100
000 in 2011, giving an APC of 12.3 % (95 % CI 4.4, 20.8)
and from 34.6 to 40.9 cases per 100 000 inhabitants in
the combination code cohort, giving an APC of 3.8 %
(95 % CI 1.3, 6.3). Within the cohort of explicit codes,
the adjusted incidence rate of cases assigned code 785.52
increased from 28.6 to 46.5 cases per 100 000 in-
habitants, giving an APC of 8.1 % (95 % CI 2.2, 14.3),
while cases identified using 995.92 changed from 7.4 to
27.3 cases per 100 000 giving an APC of 21.7 % (95 % CI
7.2, 38.1).
Mortality
Overall in-hospital mortality was 45 % (n = 100 253
cases) while 29.4 % was recorded for the combination
code cohort and 54.5 % was recorded for the explicit
code cohort. In the explicit code cohort, 39 % of deaths
(n = 29 310) were produced in critical care units, while
this figure was 20 % (n = 4962) in the combination code
cohort.
As may be observed in Table 2, in the cohort of expli-
cit codes, mortality rates were similar for cases captured
using codes 995.92 or 785.52 (54.3 % vs. 54.6 %).
From 2006 to 2011, the adjusted in-hospital mortality
rate had a significantly decreasing trend in both cohorts.
However, the combination code cohort dropped, with an
APC of −8.1 % (95 % CI −10.4, −5.7 %) while the decline,
though significant, was less pronounced in the expli-
cit code cohort with an APC over the study period
of −3.5 % (95 % CI −3.9, −3.2). Figure 3 shows the
changes detected in each cohort and explicit sub-cohorts.
In the code 785.52 group, mortality rates diminished, with
an APC of −3.5 % (95 % CI −4.0, –3.0). The 995.92 sub-
cohort had a similar decrease, with an APC of −3.5 %
(95 % CI −4.4, –2.6).
Figure 4 shows that the trend in the extent of organ
dysfunction was stable over the study period in both co-
horts. However, we detected an increase in the percent-
age of cases in which the number of organ dysfunctions
was not recorded in the explicit code cohort.
Discussion
The results of this study reveal the elevated use of expli-
cit codes to define severe sepsis in Spain and an upward
Table 1 General characteristics and in-hospital mortality recorded in the two cohorts examined (n = 222 846) (Continued)
Type of organ system dysfunctiona
Cardiovascular 97 135 (70.1) 6081 (7.2) 9.72 (9.5, 10.0)
Respiratory 68 680 (49.6) 39 679 (47.0) 1.05 (1.04, 1.07)
Renal 60 192 (43.5) 35 552 (42.2) 1.03 (1.02, 1.04)
Haematological 17 300 (12.5) 8743 (10.4) 1.20 (1.17, 1.24)
Metabolic 13 396 (9.7) 5409 (6.4) 1.51 (1.46, 1.56)
Neurological 11 232 (8.1) 12 525 (14.9) 0.55 (0.53, 0.56)
Hepatic 7687 (5.6) 4529 (5.4) 1.03 (0.99, 1.07)
Invasive therapeutic measures
Mechanical ventilation 38 450 (27.8) 13 353 (15.8) 1.75 (1.71, 1.79)
Haemodialysis 11 699 (8.5) 7847 (9.3) 0.91 (0.88, 0.93)
In-hospital death 75 495 (54.5) 24 758 (29.4) 1.86 (1.83, 1.88)
Data presented as number of cases (%). aSubgroups not mutually exclusive; borgan dysfunction without number of organs specified. RR risk ratio, CI 95 confidence
interval, COPD chronic obstructive pulmonary disease
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Table 2 Characteristics of cases identified using explicit codes (n = 138 517)
Code 785.52a
n = 93 380 (67 %)
Code 995.92a
n = 45 137 (33 %)
RR (95 % CI)
Men 54 906 (58.8) 25 196 (55.8) 1.05 (1.04, 1.07)
Age group (years)
18–44 7434 (8.0) 2921 (6.5) 1.23 (1.18, 1.28)
45–64 22 135 (23.7) 7994 (17.7) 1.34 (1.30, 1.37)
65–74 21 025 (22.5) 8350 (18.5) 1.22 (1.19, 1.25)
75–84 29 374 (31.4) 14 974 (33.2) 0.95 (0.93, 0.97)
> 84 13 412 (14.4) 10 898 (24.1) 0.59 (0.58, 0.61)
Charlson comorbidity index
0 23 482 (25.2) 9361 (20.7) 1.21 (1.18, 1.24)
1–2 43 180 (46.2) 20 640 (45.7) 1.01 (0.99, 1.03)
3–4 17 029 (18.2) 9767 (21.6) 0.84 (0.82, 0.86)
> 4 9689 (10.4) 5369 (11.9) 0.87 (0.84, 0.90)
Detailed comorbiditiesb
Diabetes 18 184 (19.5) 11 059 (24.5) 0.79 (0.78, 0.81)
Cancer 19 671 (21.1) 8393 (18.6) 1.13 (1.10, 1.16)
Chronic heart failure 13 892 (14.9) 9161 (20.3) 0.73 (0.71, 0.75)
COPD 13 488 (14.4) 7136 (15.8) 0.91 (0.89, 0.94)
Chronic renal disease 11 327 (12.1) 6948 (15.4) 0.79 (0.76, 0.81)
Liver disease 11 922 (12.8) 5486 (12.1) 1.05 (1.02, 1.08)
Cerebrovascular disease 6155 (6.6) 4239 (9.4) 0.70 (0.67, 0.73)
Dementia 4237 (4.5) 3902 (8.6) 0.52 (0.50, 0.55)
Peripheral vascular disease 4726 (5.1) 2789 (6.2) 0.82 (0.78, 0.86)
Acute myocardial infarction 3690 (4.0) 1897 (4.2) 0.94 (0.89, 0.99)
Surgical pathology 30 850 (33.0) 10 668 (23.6) 1.40 (1.37, 1.43)
Microbiological data
Identified pathogensb 35 418 (37.9) 17 528 (38.8) 0.98 (0.96, 1.0)
Gram-positive pathogens 14 318 (40.4) 7273 (41.5) 0.97 (0.95, 1.01)
Gram-negative pathogens 24 639 (69.6) 12 126 (69.2) 1.00 (0.98, 1.03)
Fungi 1043 (2.9) 478 (2.7) 1.08 (0.97, 1.21)
Site of infectionb
Respiratory system 24 476 (26.2) 10 700 (23.7) 1.11 (1.08, 1.13)
Genitourinary tract 17 462 (18.7) 11 055 (24.5) 0.76 (0.75, 0.78)
Abdomen 12 294 (13.2) 3884 (8.6) 1.53 (1.47, 1.58)
Procedure- related 9448 (10.1) 4160 (9.2) 1.10 (1.06, 1.14)
Soft tissue 3483 (3.7) 1802 (4.0) 0.93 (0.88, 0.99)
Central nervous system 991 (1.1) 434 (1.0) 1.10 (0.98, 1.24)
Cardiovascular system 884 (1.0) 398 (0.9) 1.07 (0.95, 1.21)
Others/not specified 35 257 (37.8) 17 581 (39.0) 0.97 (0.95, 0.99)
Organ system dysfunction (number of organs)
1 27 222 (29.1) 17 392 (38.5) 0.76 (0.74, 0.77)
2 30 393 (32.6) 11 601 (25.7) 1.26 (1.24, 1.29)
> 2 35 765 (38.3) 6457 (14.3) 2.68 (2.61, 2.75)
Not specifiedc Not applicable 9687 (21.5) Not applicable
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trend in this practice over the period 2006 to 2011.
Compared to combination severe sepsis codes, these
ICD-9-CM codes captured a case profile featuring
greater organ dysfunction, healthcare effort and in-
hospital mortality. These differences will have an
enormous impact on estimates of disease burden. Our
findings also indicate that cases coded with explicit
785.52 (septic shock) or 995.92 (severe sepsis) codes,
though having different characteristics, had similar
outcomes and practically the same in-hospital mortality.
Our findings are inconsistent with recent reports from
the USA such as that by Gaieski et al. [9], who in a
retrospective study based on nationwide in-patient data
for 2004 to 2009, found that only a minority of cases of
severe sepsis (between 14 % and 36.9 % according to the
capture algorithm used) were assigned explicit discharge
codes. In another retrospective study by Whittaker et al.
conducted at a single tertiary hospital [13], it was ob-
served that among 1735 cases of severe sepsis between
2005 and 2009, only 21.5 % of cases had explicit severe
sepsis/septic shock discharge codes (995.92, 785.52) and
that this trend remained stable over the period exam-
ined. In contrast, in our study over 60 % of cases in the
national health network were documented with such
codes. In addition, the implementation of these explicit
codes, especially code 995.92, had an increasing trend
Table 2 Characteristics of cases identified using explicit codes (n = 138 517) (Continued)
Type of organ system dysfunctionb
Cardiovascular 93 380 (100) 3755 (8.3) 12.0 (11.63, 12.42)
Respiratory 47 490 (50.9) 21 190 (47.0) 1.08 (1.07, 1.10)
Renal 38 789 (41.5) 21 403 (47.4) 0.88 (0.86, 0.89)
Haematological 12 220 (13.1) 5080 (11.3) 1.16 (1.13, 1.20)
Metabolic 9418 (10.1) 3978 (8.8) 1.14 (1.10, 1.19)
Neurological 7083 (7.6) 4149 (9.2) 0.83 (0.79, 0.86)
Hepatic 5197 (5.6) 2490 (5.5) 1.00 (0.96, 1.06)
Invasive therapeutic measures
Mechanical ventilation 30 569 (32.7) 7881 (17.5) 1.88 (1.83, 1.92)
Haemodialysis 9052 (9.7) 2647 (5.9) 1.65 (1.58, 1.73)
In-hospital death 50 993 (54.6) 24 502 (54.3) 1.00 (0.99, 1.02)
Data presented as number of cases (%). aCode 785.52: septic shock, code 995.92: severe sepsis; bsubgroups not mutually exclusive; corgan dysfunction without
number of organs specified. RR risk ratio, CI confidence interval, COPD chronic obstructive pulmonary disease
Fig. 1 Cases of severe sepsis identified using explicit and combination codes across the study interval. From 2006 to 2011, the number of cases
rose from 12 652 to 16 748 in the combination code cohort and from 13 156 to 30 026 in the explicit code cohort. Within this cohort, cases
coded 995.92 (severe sepsis) rose from 2697 to 11 233 and those coded 785.52 (septic shock) rose from 10 459 to 18 793
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over the six-year study period. Although the reasons for
this difference are unknown, given Spain's universal
health system, we can assume that coding practices will
not be related to financial incentives. With regards to
other factors, it is likely that the efforts to improve
coding strategies for hospital discharge registries and the
education programmes and campaigns carried out in
our country in recent years, such as the Edusepsis
campaign [32], will have improved the awareness and
training of healthcare professionals in the identification
and diagnosis of severe sepsis, leading to the observed
increased use of explicit codes.
Fig. 2 Trends in age-adjusted incidence of severe sepsis according to assigned ICD-9-CM codes. Values are adjusted annual rates. In the explicit
code cohort, adjusted incidence rates increased from 36 cases per 100 000 inhabitants in 2006 to 73.6 per 100 000 in 2011, and from 34.6 to 40.9
cases per 100,000 inhabitants in the combination code cohort. Within the cohort of explicit codes, the adjusted incidence rate of cases assigned
code 785.52 (septic shock) rose from 28.6 to 46.5 cases per 100 000 inhabitants, while cases identified using 995.92 (severe sepsis) rose from 7.4
to 27.3 cases per 100 000 inhabitants
Fig. 3 Age-adjusted in-hospital mortality rate for severe sepsis according to discharge ICD-9-CM codes. Values are adjusted annual mortality rates.
From 2006 to 2011, in-hospital mortality had a significantly decreasing trend in both cohorts. In the combination code cohort in-hospital mortality
fell from 37 % in 2006 to 25 % in 2011. In the explicit code cohort, in-hospital mortality fell from 60 % in 2006 to 50 % in 2011. Within the explicit
cohort, rates over the same period diminished from 60 % to 50.4 % in the code 785.52 group (septic shock) and from 59 % to 49.6 % in the code
995.92 group (severe sepsis)
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In line with prior findings [15, 16, 22], we detected a
marked increase in the incidence of severe sepsis
though, notably, this increase was mainly accounted for
by the cohort of explicit codes, and especially, of code
995.92. Even if the interpretation of this increase may be
confounded in part by factors such as better diagnosis of
sepsis, improvement in coding practices or other meth-
odological issues [33], the specificity of these codes [9]
suggests that the rising trend in the incidence of severe
sepsis in adults in our country may be real and not the
consequence of excessive coding of infection and organ
dysfunction [23, 34].
In addition, although the populations included in both
our cohorts should have been similar as the codes
assigned define the same disease, the patients in each
cohort had different outcomes and were only well-
matched in terms of age and sex.
In agreement with another report [13], our data indi-
cate that it was the cases of greater severity that were
assigned explicit codes, and that these codes defined a
cohort of patients who, despite having fewer comor-
bidities, had a higher rate of infection of pulmonary and
abdominal origin, more Gram-negative pathogens, and
above all, more affected organs and a higher mortality
rate. In-patient mortality for the cohort captured using
explicit codes was 54 % and practically doubled the rate
recorded for the cohort identified through combination
codes. Notably, mortality in this latter cohort was similar
to the rates reported in other population studies, such as
those of Angus [15] and Martin [16], in which combin-
ation strategies were exclusively used to identify cases,
while our rate for the explicit code cohort was consistent
with the mortality rates cited for intensive care units
[35, 36]. Furthermore, in this cohort we recorded
practically identical mortality rates among cases coded
995.92 or 785.52. While there are appreciable differences
in the demographics, comorbidities and potential
infection sources in these cases, both groups featured
similar multiple organ dysfunction and this factor likely
accounts for the high mortality observed in both sub-
cohorts [37].
Recent data indicate there is great variability in mor-
tality due to severe sepsis and septic shock which,
among other factors, seems to be related to the different
definitions used in each study [38]. In addition, studies
assessing the use of codes 785.52 (septic shock) and
995.92 (severe sepsis) have been scarce. On reanalysis,
Gaiesky [9] observed that hospital mortality among
adults with explicit codes was 36.9 % for those coded
995.92 and 42.2 % for those coded 785.52. In 373
patients coded as having severe sepsis/septic shock
(995.92, 785.52), Whittaker [13] observed 28-day mor-
tality of 41 %. However, no study has compared the
epidemiological characteristics and progression among
cases coded 995.92 and 785.52. We feel the novelty of
our work is that this type of comparison was performed
using a national population database including a large
number of cases and a representative case-mix. Very
probably, because of the new sepsis definitions [39] in
which the use of explicit codes is recommended,
new studies with which to compare our findings will
soon emerge.
Fig. 4 Trends in the number of organ dysfunctions recorded in the two cohorts examined. Values are percentages. In the explicit code cohort,
34 % of cases involved single organ dysfunction, 32.7 % two organs and 29.4 % more than two affected organs in 2006 versus 30.7 %, 30.2 %
and 31.3 %, respectively in 2011. In 2006, the number of dysfunctional organs was not specified in 3.9 % compared with 8 % in 2011. In the
combination code cohort, 70.3 % of cases involved single organ dysfunction, 21.6 % two affected organs and 8.4 % more than two affected
organs in 2006 versus 73.1 %, 20.8 % and 6.1 %, respectively in 2011
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The high percentage of cases assigned explicit codes
and their high mortality rate, in large measure explains
the differences observed in in-hospital mortality between
the present and other population studies including a
lower percentage of cases captured by explicit severe
sepsis codes. Further, although mortality in our study
had an overall declining trend from 2006 to 2011, this
decline was significantly lower in the explicit code co-
hort. Thus, although our data reflect the decreasing
trend in hospital mortality due to severe sepsis in adult
patients observed in other studies [9, 16, 40, 41], it re-
mains clear that this trend is more limited in cases of
greater disease severity. Interestingly, in both our co-
horts a stable trend in the extent of organ dysfunction
was produced, which despite not confirming recently
published data from the USA [34], could nevertheless
explain, at least partly, the observed downward trend in
mortality.
The elevated proportion of hospitalizations assigned
explicit codes observed in our study is perfectly in line
with the new definitions of sepsis and recommendations
for the use of ICD-9 codes 995.92 and 785.52 [39] for
such cases. In effect, although the implementation of
these explicit codes is not yet complete in Spain, it is still
high and shows an increasing trend. Consistent with
these recommendations [39], we predict that better un-
derstanding of the concept and definition of severe sep-
sis through continued education programmes will
improve its description in clinical records and thus allow
for a more consistent measure of the burden of severe
sepsis and its trends.
The limitations of our study are those inherent to
investigations based on retrospectively collected clinical-
administrative data. Although there are national direc-
tives for the use of the ICD-9-CM coding system, this
may not have been uniform across all hospitals of the
national health network and we cannot rule out coding
errors despite regular audits making major errors un-
likely. We are also aware that, because of its confidential
nature, the database used lacks sufficient information
and the data do not allow for causal inferences. How-
ever, the use of such databases is well-established in
severe sepsis epidemiology and the results of a recent
meta-analysis clearly support the use of administrative
data to monitor mortality trends in severe sepsis [41],
confirming the essential role of the consistent use of
national administrative data for epidemiological moni-
toring of incidence and outcomes [9, 10].
Our country has a large national population-based
database covering over 90 % of all hospitalizations
produced annually in the country. There are potential
benefits of this system including representativeness,
identification of systemic problems, and precision of
estimation in statistical analysis. Additionally, this study
followed the publication guidelines for observational
studies laid down in the strengthening the reporting
of observational studies in epidemiology (STROBE)
initiative [42].
A limitation of our study was that non-hospitalized
patients with severe sepsis were not included, meaning
that incidence was really an estimate of treated sepsis
[43]. Similarly, our mortality estimates were conservative
in that we did not include mortality after hospital dis-
charge [3, 5, 44].
Conclusions
Our study reveals an elevated and increasing use of
explicit coding practices for adult severe sepsis in Spain.
This trend will have substantial impacts on epidemio-
logical and disease burden estimates, because cases are
registered of greater severity, care intensity and in-hospital
mortality. The variation detected in severe sepsis coding
and its effects on population estimates calls for improved
continuous education for physicians and the introduction
of standardized measures targeted at reducing heterogen-
eity in coding practices.
Key messages
 In Spain over the period 2006–2011, some 62 % of
adult severe sepsis cases in this population-based
study were assigned explicit ICD-9-CM codes.
 This elevated and increasing use of explicit codes for
adult severe sepsis has substantial impacts on
epidemiological estimates, because these codes
capture a case profile featuring extensive organ
dysfunction, care effort and in-hospital mortality.
 Variability in severe sepsis coding practices must be
taken into account when interpreting
epidemiological estimates.
 Inconsistencies in medical coding practices call for
the implementation of sepsis education programmes
for health professionals.
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